MGH IBS Study
Share
Tenapanor is the newest FDA-approved agent for irritable bowel syndrome with constipation (IBS-C).
We are conducting a study to better understand how tenapanor affects the microbiome of patients with IBS-C through stool sample analysis.
Want your practice to be the top-listed Clinic in Boston?
Click here to claim your Sponsored Listing.
Click here to claim your Sponsored Listing.
Category
Address
55 Fruit Street
Boston, MA
02114